ARLENE ALEGRIA: Open Payments
NPI 1487016366 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 74 payments from 30 companies in 2025. Trend: 2023 $612 · 2024 $558 · 2025 $2,010
Food & beverage: $1,712Education: $298
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $192 |
| Daiichi Sankyo Inc. | 10 | $177 |
| Gilead Sciences, Inc. | 4 | $158 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| Inspire Medical Systems, Inc. | 1 | $137 |
| Exelixis Inc. | 2 | $124 |
| Genentech USA, Inc. | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Celgene Corporation | 4 | $91 |
| PFIZER INC. | 4 | $79 |
Products named: Dexcom G6 Transmitter, Enhertu, Trodelvy, INSPIRE, SARCLISA, REBLOZYL, VENCLEXTA, Fabhalta.
Industry payments across TX — which companies pay providers there.
